174180-46-2

Upstream product

• 534-85-0 N-phenyl-1,2-benzenediamine 
• 106-95-6 allyl bromide 
• 174180-28-0 2-(2,4-Dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl)-N-isopropyl-N-phenyl acetamide 
• 161455-90-9 N-isopropyl-N-phenyl-2-(2-phenylamino-phenylamino)-acetamide 
• 161455-97-6 2-bromo-N-isopropyl-N-phenyl-acetamide 

Downstream Products

• 174180-47-3 2-(3-Allyl-3-methyl-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl)-N-isopropyl-N-phenyl acetamide 
• 174180-64-4 [1-(isopropyl-phenyl-carbamoylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl]acetic acid 

Relevant academic research and scientific papers

3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: Orally active, binding selective CCK-A agonists

A series of modifications were made to the C-3 substituent of the 1,5- benzodiazepine CCK-A agonist 1. Replacement of the inner urea NH and addition of a methyl group to generate a C-3 quaternary carbon resulted in acetamide 6, which showed CCK-A receptor